Introduction
Critically ill mechanically ventilated patients are usually stratified in two levels according to the risk for reintubation. In low-risk patients high flow conditioned oxygen therapy (HFO) may reduce reintubation, whereas in high-risk patients non-invasive mechanical ventilation (NIMV) to prevent reintubation is gaining acceptance. However, data on the efficacy or safety of HFO in highrisk patients are lacking.
Objectives
We hypothesized that HFO is an appropriate alternative to NIMV in preventing reintubation in high risk patients. The primary outcome was all-causes and respiratory-related reintubation rate within 72 hours.
Methods
In this multicenter, randomized, noninferiority trial, we recruited 603 critically ill patients at high-risk for reintubation to be treated after extubation with either HFO (n = 290) or NIMV (n = 313). High-risk for reintubation was defined as the presence of at least any of the following criteria: >65 years, cardiac failure, moderate-to-severe COPD, APACHE II >12 points at extubation day, body mass index >30, airway patency problems, inadequate secretions management, not simple weaning, ≥2 comorbidities, and prolonged mechanical ventilation. NIMV as a rescue therapy was not allowed in the HFO group. Noninferiority was determined as a < 6% absolute difference in the risk of the primary outcome.
Results
Respiratory-related reintubations occurred in 49 (16.9%) HFO patients and in 50 (16%) NIMV patients (risk difference 0.9%; upper limit of the unilateral 95%CI 5.9). All-causes reintubation occurred in 67 (23.1%) HFO patients and in 60 (19.2%) NIMV patients (risk difference 3.9%; upper limit of the unilateral 95%CI 9.4%).
Conclusions
In critically ill patients at high risk, HFO was noninferior to NIMV in preventing respiratory-related reintubation, but not all-causes reintubation. The study was registered at ClinicalTrials.gov (Identifier: NCT01191489).
